Patents by Inventor CHRISTOPHER NESSEL

CHRISTOPHER NESSEL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MILVEXIAN FOR PREVENTION AND TREATMENT OF THROMBOEMBOLIC DISORDERS
    Publication number: 20250099466
    Abstract: The factor Xia inhibitor milvexian has therapeutic properties useful in the treatment and/or prevention of thrombotic and thromboembolic disorders.
    Type: Application
    Filed: September 16, 2022
    Publication date: March 27, 2025
    Inventors: John STRONY, Gary PETERS, Madhu CHINTALA, Christopher NESSEL, Liyanage Vidya PERERA, Danshi LI, Joseph M. LUETTGEN, Dietmar Alfred SEIFFERT, Charlotte JONES-BURTON
  • METHODS OF THROMBOPROPHYLAXIS
    Publication number: 20220193085
    Abstract: Methods of thromboprophylaxis using rivaroxaban is provided for children with congenital heart disease post-Fontan procedure.
    Type: Application
    Filed: December 16, 2021
    Publication date: June 23, 2022
    Applicants: JANSSEN PHARMACEUTICALS, INC., BAYER PHARMA ATKIENGESELLSCHAFT
    Inventors: CHRISTOPHER NESSEL, Stefan Willmann, Dagmar Kubitza, Roger M. Mills, Catherine Vanden Boom, Elliot Barnathan, Liza Miriam Pina